Related Experiment Videos

Anti-fibrosis therapy and diabetic nephropathy

Anil Karihaloo1

  • 1Section of Nephrology, Yale University School of Medicine, New Haven, CT 06520, USA. anil.karihaloo@yale.edu

Current Diabetes Reports
|May 31, 2012
PubMed

Insights

Diabetic nephropathy, a common diabetes complication, leads to kidney fibrosis. Current treatments are limited, but new research focuses on halting or reversing this fibrosis.

Area of Science:

  • Nephrology
  • Endocrinology
  • Diabetology

Background:

  • Diabetes mellitus is a growing global health concern with significant impact on multiple organ systems.
  • Diabetic nephropathy is a prevalent complication of diabetes, often developing insidiously.
  • Existing treatments for overt diabetic nephropathy, beyond ACE inhibitors and ARBs, are limited.

Purpose of the Study:

  • To review the current research landscape for diabetic nephropathy.
  • To discuss the challenges and progress in understanding and treating kidney fibrosis in diabetic nephropathy.
  • To highlight the need for novel therapeutic targets for fibrotic kidney disease.

Main Methods:

  • This review synthesizes current research on diabetic nephropathy.
  • It examines the multifactorial etiology and pathogenic pathways contributing to kidney dysfunction.
  • The review discusses the limitations in experimental models for studying fibrosis.

Main Results:

  • Kidney fibrosis is a common endpoint for patients with diabetic nephropathy and chronic kidney disease.
  • Despite extensive research, effective therapeutic targets for fibrosis remain scarce.
  • There is a growing pharmaceutical interest in developing antifibrotic therapies for diabetic nephropathy.

Conclusions:

  • Effective treatments for diabetic nephropathy, particularly for fibrosis, are urgently needed.
  • Advancements in understanding fibrotic pathways and improved experimental models are crucial for therapeutic development.
  • Future research efforts are focused on halting, delaying, or reversing kidney fibrosis in diabetic patients.

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...